SIGA Technologies, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
SIGA Technologies, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does SIGA Technologies, Inc. do? Business model and key facts
Get the full picture of SIGA Technologies, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees (FY): 49
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Stocks related to SIGA Technologies, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting SIGA Technologies, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
SIGA Technologies, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
